Safety and Effectiveness of Vedolizumab in Patients with Moderate-to-Severe Ulcerative Colitis: An Interim Analysis of a Japanese Post-Marketing Surveillance Study.
Katsuyoshi MatsuokaTadakazu HisamatsuYohei MikamiTakayuki YamamotoSatoshi MotoyaShinichiro ShinzakiRyuichi IwakiriKenkichi SugiuraKunihiko NishimuraMika KajitaJovelle L FernandezPublished in: Advances in therapy (2023)
JapicCTI-194603, NCT03824561.